Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study

NCT02211482 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: dolutegravir, lamivudine

Sponsor

Fundación Huésped

Collaborators

[object Object]